Navigation Links
Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
Date:2/5/2008

ers of RBC destruction (hemolysis) in SCD patients. The investigators also sought to obtain additional safety data and identify the optimal dose for a phase III study. The primary efficacy endpoint was the change in blood hemoglobin level from baseline to end of study, and secondary endpoints included markers of hemolysis, changes in RBC count and indices, and frequency of painful events or "crises."

"An understanding of the pathophysiology of sickle cell disease is extremely important in order to identify new therapeutic targets," said Kenneth Ataga, MD, of the Division of Hematology/ Oncology at the University of North Carolina at Chapel Hill and lead author of the study.

A total of 90 eligible patients were enrolled in the trial. Of these participants, 24 were also taking hydroxyurea, a drug already approved for the treatment of SCD. The patients were randomized into three treatment arms: placebo (n=30), low-dose senicapoc (6 mg/day, n=29), and high-dose senicapoc (10 mg/day, n=31). Safety and efficacy assessments were obtained at the end of week one and then every two weeks until completion of the study treatment.

Patients treated with senicapoc achieved measurable improvements in hemoglobin levels. Patients in the high-dose senicapoc arm achieved a hemoglobin increase of 0.68 g/dL (vs. 0.01 g/dL for patients taking placebo). The team also found corresponding increases in hematocrit and RBC count in the patients taking senicapoc when compared to placebo. Notably, the sub-groups of patients taking hydroxyurea achieved similar results. In the low-dose group, the increase in hemoglobin compared to placebo was not statistically significant.

Treatment with senicapoc also produced dose-dependent and statistically significant improvements in secondary endpoints, including the percentage of dense RBCs (-2.41 vs. -0.08, high-dose vs. placebo), reticulocytes (-4.12 vs. -0.46), and lactate dehydrogenase (-121 vs. -15), a marker o
'/>"/>

Contact: Laura Stark
lstark@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel vaccine concept developed by scientists at the Wistar Institute
2. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
3. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
4. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
5. New method enables design, production of extremely novel drugs
6. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
7. Speedy Procedures Demonstrate Excitement and Continued Interest in Novel Multi-Electrode Ablation System
8. Novel anticancer strategy moves from laboratory to clinic
9. FDA approves Bystolic, a novel beta blocker
10. Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year
11. Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... recently used birth control pills containing high-dose estrogen and ... breast cancer, whereas women using some other formulations did ... , a journal of the American Association for Cancer ... oral contraceptives [birth control pills] in the past year ... to never or former oral contraceptive use, and that ...
(Date:7/31/2014)... July 31, 2014 Developer Jamestown, L.P., ... on its Ponce City Market project in Atlanta’s Old ... Roebuck & Company building into best-in-class office, housing, and ... reviewed Jamestown’s experience with their construction webcam service to ... Jamestown wanted a construction camera for monitoring ...
(Date:7/31/2014)... July 31, 2014 Leelanau Peninsula’s newest winery, ... 3, 2014 at 7788 East Horn Road in Lake Leelanau. ... Trail , Aurora Cellars is the 25th winery along the ... the popular wine tour events, making its trail event debut ... 2014. , Owners David and Faye Mathia opened the ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are now offering ... Systematic Review of Sexual Satisfaction . The ... Journal of Clinical and Health Psychology. , This CE ... to have accurate information about sexual satisfaction so that ... The material provides a systematic review of 197 research ...
Breaking Medicine News(10 mins):Health News:Recent use of some birth control pills may increase breast cancer risk 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3
... (May 14, 2012) - A team of international scientists has ... duct cancer, a deadly type of liver cancer. By identifying ... are paving the way for better understanding of how bile ... Nature Genetics . Bile Duct Cancer, or Cholangiocarcinoma, is ...
... S.C. - Clemson University researcher Julia Frugoli has received ... four-year grant from the National Science Foundation to continue ... with each other to control their growth and development. ... Clemson University,s College of Agriculture, Forestry & Life Sciences, ...
... , MONDAY, May 14 (HealthDay News) -- Feeding tubes ... according to a new study. The finding challenges the ... bed sores or helps promote their healing in this group ... The researchers did not look at how feeding tubes ...
... May 14, 2012 Persistent Systems (BSE & ... (OPD) services, and the Translational Genomics Research Institute (TGen) ... management system called Bio4D. Initial versions of the ... and genomic research, have been used at TGen in ...
... Storrs HealthDay Reporter , MONDAY, May 14 (HealthDay ... or running while toting a bottle, a pacifier or a ... nationwide survey, researchers estimated that more than 45,000 visits to ... 3 years old were because of injuries related to using ...
... News) -- Doing more repetitions with less weight builds ... with heavy weights, a new Canadian study indicates. ... to the point of fatigue, according to the researchers ... how different combinations of weight loads and repetitions affected ...
Cached Medicine News:Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 2Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 3Health News:Clemson professor awarded nearly $600,000 4-year grant to study language of plants 2Health News:For Dementia Patients, Feeding Tubes May Increase Bed Sores 2Health News:New biospecimens management system in development 2Health News:Baby Bottles, Pacifiers, Sippy Cups Can Injure 2Health News:Baby Bottles, Pacifiers, Sippy Cups Can Injure 3Health News:With Weights, You Can Lighten Your Load 2
(Date:7/31/2014)... , July 31, 2014  Zacks.com announces the list ... Zacks Equity Research analysts discuss the latest news and events ... the blog include the Biogen (Nasdaq: BIIB - Free Report ... Biotechnology (NYSE: PBYI - Free Report ), AbbVie (NYSE: ... CELG - Free Report ). Today, Zacks is ...
(Date:7/31/2014)... , July 31, 2014 Vermillion, Inc. (NASDAQ: ... women,s health, will hold a conference call on Thursday, August ... for the second quarter ended June 30, 2014. Financial results ... call. Vermillion,s Chairman, President and CEO James ... and answer period. Date: Thursday, August 14, 2014 ...
(Date:7/31/2014)... 31, 2014 TB Alliance, a not-for-profit ... faster and affordable treatments, announced the appointment of ... External Affairs. Mr. Brock comes to TB Alliance ... Donor Relations for WWF International (formerly known as ... Brock will guide the TB Alliance,s resource development, ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... , , , BOSTON, Sept. ... financial gift to the Harvard Stem Cell Institute (HSCI) Seminar Series ... Terms of the gift were not disclosed. , , ... stem cell science community in which pioneers in the national and ...
... , SAN DIEGO, Sept. 1 ... in adult stem cell research and manufacturing, announced today that it ... & Drug Branch to manufacture stem cells for human clinical trials. ... law and the applicable provisions of the Code of Federal Regulations. ...
Cached Medicine Technology:Stemgent Announces Sponsorship of Harvard Stem Cell Institute Seminar Series; 2Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 2
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Medicine Products: